Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(OP:
MEDIF
)
0.0443
-0.0027 (-5.74%)
Streaming Delayed Price
Updated: 3:30 PM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medipharm Labs Corp
< Previous
1
2
3
4
Next >
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
November 14, 2024
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024...
Via
Benzinga
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024
August 14, 2024
MediPharm Labs just reported results for the second quarter of 2024.
Via
InvestorPlace
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
August 14, 2024
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report- Monday, Aug 12
August 13, 2024
The past, present and future of the Canadian cannabis sector.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
August 09, 2024
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024
May 15, 2024
MediPharm Labs just reported results for the first quarter of 2024.
Via
InvestorPlace
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
July 03, 2024
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
June 20, 2024
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
May 15, 2024
Via
Benzinga
The Canadian Cannabis Report - Monday, April 22
April 22, 2024
The past, present and future of the Canadian cannabis sector, based on the performanceof the MCCCI, which is a proprietary index of 14 stocks.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023
March 27, 2024
MediPharm Labs just reported results for the fourth quarter of 2023.
Via
InvestorPlace
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...
Via
Benzinga
The Canadian Cannabis Report - Monday, March 25
March 27, 2024
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 14 stocks
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
February 07, 2024
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
November 14, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of...
Via
Benzinga
New Cannabis Products Energize Global Health & Wellness Market, Including Australia
October 16, 2023
In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
October 02, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis
Via
Benzinga
New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
September 28, 2023
MediPharm Labs Corp.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Canadian Cannabis Report - Monday, Sept. 25
September 25, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietarey index of 15 stocks.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
September 20, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C.
Via
Benzinga
Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found
August 31, 2023
New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For August 23, 2023
August 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
August 14, 2023
Cannabinoid-focused pharmaceutical company MediPharm Labs Corp.
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.